NDC 75834-147-06 - HYDROCORTISONE ACETATE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 75834-147
- Requested NDC
- 75834-147-06
- Package NDCs from labels
- 75834-147-06, 75834-147-12, 75834-147-24
- Manufacturer
- Nivagen Pharmaceuticals, Inc.
- Effective date
- 2023-08-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hydrocortisone Acetate, 25 mg Rectal Suppositories | Nivagen Pharmaceuticals, Inc. | 2023-08-28 | HUMAN PRESCRIPTION DRUG LABEL |
| HYDROCORTISONE ACETATE - A-S Medication Solutions | A-S Medication Solutions | 2021-09-29 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 75834-147-12 | 2023-08-28 | Hydrocortisone Acetate, 25 mg Rectal Suppositories |
| 75834-147-24 | 2023-08-28 | Hydrocortisone Acetate, 25 mg Rectal Suppositories |
| 75834-147-12 | 2023-01-30 | Hydrocortisone Acetate, 25 mg Rectal Suppositories |
| 75834-147-24 | 2023-01-30 | Hydrocortisone Acetate, 25 mg Rectal Suppositories |
| 75834-147-12 | 2021-09-23 | Hydrocortisone Acetate, 25 mg Rectal Suppositories |
| 75834-147-24 | 2021-09-23 | Hydrocortisone Acetate, 25 mg Rectal Suppositories |
| 75834-147-12 | 2021-07-23 | Hydrocortisone Acetate, 25 mg Rectal Suppositories |
| 75834-147-24 | 2021-07-23 | Hydrocortisone Acetate, 25 mg Rectal Suppositories |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 75834-147-06 | HYDROCORTISONE ACETATE | 6 in 1 BLISTER PACK | SUPPOSITORY | 6 | 4 | |
| 75834-147-12 | HYDROCORTISONE ACETATE | 2 in 1 CARTON | SUPPOSITORY | 2 | 4 | |
| 75834-147-24 | HYDROCORTISONE ACETATE | 4 in 1 CARTON | SUPPOSITORY | 4 | 4 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 75834-147-12 | EA - Each | 75834-147 | 531486e6-0ff5-40d3-bc55-77f25d3e9c87 | 1 | 2020-08-06 |
| 75834-147-24 | EA - Each | 75834-147 | b61d26d7-52bb-46d4-b3ba-6cca3630a48a | 1 | 2020-08-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Thompson Hydrocortisone 1% | HYDROCORTISONE | Thompson | f8740314-7e1f-815e-e053-6294a90a6eae | 2025-12-05 | Warnings | 3X7931PO74 |
| Hydrocortisone Acetate Antipruritic (Anti-Itch) | HYDROCORTISONE ACETATE | Sun Pharmaceutical Industries, Inc. | 9f0b09e7-6cfd-4fd6-8631-67799edf4e08 | 2025-12-02 | Warnings | 3X7931PO74 |
| Hydrocortisone Acetate | HYDROCORTISONE ACETATE | Marlex Pharmaceuticals, Inc. | e60473f7-fd00-a477-e053-2a95a90ad4dd | 2025-11-13 | Adverse reactions | 1291082 3X7931PO74 |
| Analpram HC | HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE | Sebela Pharmaceuticals Inc. | fecf8380-3bb5-11e5-98c5-0002a5d5c51b | 2025-11-08 | Adverse reactions | 3X7931PO74 |
| Analpram HC | HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE | Sebela Pharmaceuticals Inc. | 1469733e-1723-4b8c-be33-ed8dfafd65e2 | 2025-11-08 | Adverse reactions | 3X7931PO74 |
| Pramosone | HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE | Sebela Pharmaceuticals Inc. | f207bdff-2f41-4eee-818e-198b6462863e | 2025-11-08 | Adverse reactions | 3X7931PO74 |
| Hydrocortisone Acetate Pramoxine Hcl | HYDROCORTISONE ACETATE PRAMOXINE HCL | Bryant Ranch Prepack | a6a5e63c-29ca-4d30-b8b6-b3bd18a25c38 | 2025-10-24 | Adverse reactions | 3X7931PO74 |
| Medi-First Hydrocortisone 1% | HYDROCORTISONE ACETATE 1% | Unifirst First Aid Corporation | f2b46d69-1c21-5ae9-e053-2a95a90a60a9 | 2025-10-24 | Warnings | 3X7931PO74 |
| hydrocortisone acetate pramoxine HCl | HYDROCORTISONE ACETATE, PRAMOXINE HCL | Bryant Ranch Prepack | d59665d7-a0f4-4318-b452-171c54ed156c | 2025-10-24 | Adverse reactions | 3X7931PO74 |
| Hydrocortisone Acetate Pramoxine Hcl | HYDROCORTISONE ACETATE PRAMOXINE HCL | Bryant Ranch Prepack | f219b99e-9b73-4021-9d4c-8c7b0f129c93 | 2025-10-24 | Adverse reactions | 3X7931PO74 |
| Hydrocortisone Acetate Pramoxine Hcl | HYDROCORTISONE ACETATE PRAMOXINE HCL | Bryant Ranch Prepack | 26c380c0-5b11-4b11-a5a6-823510b0fd0f | 2025-10-24 | Adverse reactions | 3X7931PO74 |
| Vanicream HC Anti-Itch | HYDROCORTISONE | Pharmaceutical Specialties, Inc. | 28b06507-27a5-2cb1-e054-00144ff8d46c | 2025-10-14 | Warnings | 3X7931PO74 |
| HYDROCORTISONE | HYDROCORTISONE | HF Acquisition Co LLC, DBA HealthFirst | 3ba6a5ec-fda2-b2a6-e063-6294a90ac9b6 | 2025-08-05 | Warnings | 3X7931PO74 |
| Hydrocortisone Acetate | HYDROCORTISONE ACETATE | Major Pharmaceuticals | 1281a82d-df00-4421-9c0d-951f8f9a9422 | 2025-08-05 | Adverse reactions | 1291082 3X7931PO74 |
| Hydrocortisone Acetate Cream | HYDROCORTISONE ACETATE CREAM | Allegis Holdings LLC | 3b008546-afa5-fe5a-e063-6394a90adb3b | 2025-07-28 | Adverse reactions | 3X7931PO74 |
| Hydrocortisone | HYDROCORTISONE ACETATE | Rite Aid Corporation | cb6e0bed-2ea1-49d2-89e7-2554e7565b74 | 2025-07-11 | Warnings | 3X7931PO74 |
| Hydrocortisone | HYDROCORTISONE ACETATE | Walgreen Company | bff322f1-59c3-41e0-8685-fcfe52bf4b42 | 2025-07-10 | Warnings | 3X7931PO74 |
| Pramosone Cream | HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE | Legacy Pharma USA Inc. | 6a9fb75b-a2f7-4eca-8dce-d7eb5c122476 | 2025-06-30 | Adverse reactions | 3X7931PO74 |
| Analpram HC | HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE | Legacy Pharma USA Inc. | 39618fc5-87a8-47bc-93fc-cb97b8f663c8 | 2025-06-24 | Adverse reactions | 3X7931PO74 |
| Analpram HC | HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE | Legacy Pharma USA Inc. | 56568e1f-974b-4750-b560-d93eb5e0e83f | 2025-06-09 | Adverse reactions | 3X7931PO74 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.